BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 214 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2023. The put-call ratio across all filers is 2.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,179,670 | -62.0% | 381,913 | -52.2% | 0.01% | -60.7% |
| Q2 2023 | $50,520,879 | +41.4% | 799,381 | +0.7% | 0.03% | +27.3% |
| Q1 2023 | $35,725,254 | +96622.0% | 794,071 | -5.8% | 0.02% | -12.0% |
| Q4 2022 | $36,936 | -99.9% | 843,090 | +16.2% | 0.02% | -30.6% |
| Q3 2022 | $47,806,000 | +65.9% | 725,537 | +27.2% | 0.04% | +80.0% |
| Q2 2022 | $28,817,000 | +13.3% | 570,511 | +43.3% | 0.02% | +33.3% |
| Q1 2022 | $25,428,000 | -40.7% | 398,055 | -0.6% | 0.02% | -37.5% |
| Q4 2021 | $42,873,000 | +32.1% | 400,273 | +26.8% | 0.02% | +20.0% |
| Q3 2021 | $32,453,000 | – | 315,658 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 716,539 | $36,192,000 | 12.35% |
| CADIAN CAPITAL MANAGEMENT, LP | 2,020,629 | $102,062,000 | 6.89% |
| Casdin Capital, LLC | 1,150,000 | $58,087,000 | 4.91% |
| DAFNA Capital Management LLC | 261,280 | $13,197,000 | 3.60% |
| Nextech Invest Ltd. | 188,228 | $9,507,000 | 3.21% |
| Eagle Health Investments LP | 170,551 | $8,615,000 | 2.01% |
| Boxer Capital, LLC | 507,374 | $25,627,000 | 1.62% |
| Rock Springs Capital Management LP | 979,174 | $49,458,000 | 1.44% |
| EFG Asset Management (North America) Corp. | 130,454 | $6,589,000 | 1.39% |
| Integral Health Asset Management, LLC | 130,000 | $6,566,000 | 1.35% |